Skip to main content

Advertisement

Table 4 Associationa between the level of satisfaction to care coordination and worse clinical outcomes, poor quality of life and fear of recurrence

From: Association between perception of care coordination and health outcomes in Korean cancer survivors

Clinical outcomes (cut-off level)Coordinated group (reference)Intermediate groupUncoordinated groupP-trenda
OROR (95% CI)OR (95% CI) 
New comorbidity after cancer diagnosis (≥1)11.16 (0.79,1.69)1.73 (1.02,2.92)0.013
Multiple clinic visiting (≥2)11.18 (0.83,1.68)1.69 (1.00,2.88)0.010
Quality of life indices (cut-off level)
 Low EQ_VAS (< 60)11.41 (1.10,1.82)1.82 (1.28,2.60)0.001
Low level of EORTC QLQ-C30
 Low Global health status/QOL (< 50.00)11.45 (1.10,1.89)1.51 (1.04,2.21)0.012
 Low physical functioning (< 73.33)11.31 (0.96,1.80)2.00 (1.31,3.04)0.005
 Low role functioning (< 66.67)11.73 (1.31,2.27)2.46 (1.69,3.56)< 0.001
 Low emotional functioning (< 66.67)11.91 (1.46,2.48)2.62 (1.81,3.78)< 0.001
 Low cognitive functioning (< 66.67)10.99 (0.77,1.26)1.57 (1.11,2.22)0.025
 Low social functioning (< 66.67)11.30 (0.76,2.24)2.07 (1.42,3.03)0.001
K-FCRI
 Triggers (≥17)11.46 (0.95,2.25)1.90 (1.06,3.42)0.062
 Severity (≥16)11.68 (1.14,2.49)2.28 (1.33,3.93)0.003
 Psychological distress (≥7)11.68 (1.06,2.66)2.47 (1.35,4.52)0.008
 Functional impairment (≥8)11.12 (0.72,1.74)1.24 (0.67,2.28)0.758
 Coping strategies (< 15)12.51 (1.52,4.14)2.49 (1.27,4.88)< 0.001
 Insight (≥2)10.69 (0.39,1.21)0.74 (0.33,1.63)0.410
 Reassurance (< 2)11.45 (0.83,2.54)1.36 (0.61,3.00)0.410
  1. OR (95%CI) odds ratio (95% confidence interval), EQ-VAS EuroQoL Visual Analogue Scale, EORTC QLQ-C30 The European Organization for Research and Treatment of Cancer 30-item quality of life questionnaire, QOL quality of life and K-FCRI Korean version of fear of cancer recurrence index
  2. We defined the cut-off level of low EQ_VAS, low EORTC QLQ-C30 and increased fear of cancer recurrence as the forth quartile of them
  3. aEvaluated by multiple logistic regression analysis after adjusting for age, sex, cancer site, marital status, cancer stage, treatment modality, type of care providers and duration since cancer diagnosis